Welcome : Guest

NeuroDerm Ltd. (Israel) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about NeuroDerm Ltd., which is principally a Clinical-Stage Pharmaceutical Company. Illustrated with 18 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64976
Price: $900
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anti-Psychotics......3
Table 1: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......3
Table 2: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......4
Central Nervous System (CNS) Drugs......5
Table 3: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......5
Table 4: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......6
Depression Drugs......7
Table 5: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......7
Parkinson's Disease......8
Table 6: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......8
Table 7: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......9
Seizure Disorders......10
Table 8: Seizure Disorder Market by Type of Drug in the US (2015) - Percentage Share Breakdown by Value for Carbamazepine, Clonazepam, Gabapentin, Lamotrigine, Levetiracetam, Valproic Acids and Others......10
Anatomical Therapeutic Chemical (ATC-3) Indications......11
Table 9: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2015) - Percentage Share Breakdown by Value Sales for A10C Human Insulin and Analogs, C09D Angiotensin II Antagonists, L01X Other Antineoplastic Agents, L03B Interferons, L04B Anti-TNF Preparations, L04X Other Immunosuppressants, N02A Analgesics, Narcotics, N03A Antiepileptics, N05A Antipsychotics, T02D Diabetes Tests, and Others......11
Antipsychotic Drugs......12
Table 10: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......12
Table 11: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......13
Table 12: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......14
Acute Behavioural Treatment......15
Table 13: Market Shares of Leading Acute Behavioural Treatment Service Providers Worldwide (2015) - Percentage Breakdown by No. of Beds for Accreditation Commission for Health Care, Inc. (ACHC), Aurora Behavioral Health Care, Universal Health Services, Inc., and Others......15
Central Nervous System (CNS) Medicines......16
Table 14: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......16
Table 15: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......17
Insomnia Drugs......18
Table 16: Market Shares of Leading Insomnia Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Jazz Pharmaceuticals (JAZZ), Sanofi S.A. (SNY), Somaxon Pharmaceuticals, Inc. (SOMX), Takeda Pharmaceutical Company Limited, Generics, and Others......18
Prescribed Atypical Antipsychotic......19
Table 17: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......19
Table 18: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......20